The Health Service Medical Supplies (Costs) Bill was introduced into the House of Lords on 7 December 2016 and is due to receive its second reading on 21 December 2016. The Bill seeks to amend and extend the provisions of the National Health Service Act 2006 which relate to the control of the cost of both health service medicines and other medical supplies.
Health Service Medical Supplies (Costs) Bill: Briefing for Lords Stages (286 KB , PDF)
The NHS in England spent £15.2 billion on medicines during the financial year 2015/16; a rise of over 20 percent since 2010/11. Currently, the cost of branded medicines is regulated primarily through a voluntary scheme; manufacturers/suppliers who do not join the voluntary scheme automatically join a statutory scheme. Unbranded, or generic medicines, are not regulated and rely on competition to keep prices down. Recent price increases of some generic medicines have led to concern that not enough is being done to regulate their price. In addition, income from the voluntary scheme has reduced and some manufacturers/suppliers have chosen to join the statutory scheme, which does not involve the same payments to the Government under the voluntary scheme.
The Bill includes provisions to bring the current statutory medicines pricing scheme, which applies to branded medicines, into line with the voluntary scheme: the Pharmaceutical Price Regulation Scheme (PPRS). The Bill would also allow the Secretary of State to make regulations to limit prices of, or profits relating to, unbranded medicines. Currently, the Government cannot apply price controls to the unbranded generic medicines of those companies who are members of the PPRS; the Bill would remove this loophole. In addition, the Bill would introduce a new power regarding information provision, which would enable the Secretary of State to make regulations to obtain information about health service medicines and other supplies from all parts of the supply chain. The information would be used for defined purposes, set out in the Bill.
The Bill was broadly welcomed by Labour, the Scottish National Party and the Liberal Democrats. Several government amendments were made at committee stage and a new clause was added, relating to the information provision requirements in the Bill. A small number of government amendments were also made at report stage. No non-government amendments were successful at either committee or report stage. An amendment to ring fence the money collected through the voluntary scheme to invest in “access to new and innovative medicines and treatments”, was defeated on division at committee stage, as was another to specify reporting requirements that the Secretary of State should follow in assessing the impact of the Bill. This briefing provides an overview of the clauses of the Bill and details its passage through the House of Commons in advance of the Bill’s second reading in the House of Lords.
Health Service Medical Supplies (Costs) Bill: Briefing for Lords Stages (286 KB , PDF)
The bill aims to create a 'smoke-free generation' by banning tobacco sales to anyone born on or after 1 January 2009, alongside other measures to tackle smoking and tobacco harms. It would also further regulate vaping, curbing its appeal to children, while enabling adult smokers to use vapes as a quitting tool. The bill is similar to the Tobacco and Vapes Bill which fell at dissolution 2024.
In October 2024, a report from the House of Lords Food, Diet and Obesity Committee concluded that poor-quality diets were contributing to an obesity crisis in England. It said that successive governments had failed to tackle the issue, and more regulation was now needed. This briefing summarises the committee’s recommendations, the government’s response in January 2025, and reaction to both reports.
On 9 March, the Covid-19 Day of Reflection 2025 took place to mark five years since the start of the pandemic in the UK. This briefing has been prepared ahead of a debate in the House of Lords focused on the support available to those bereaved because of Covid-19. It outlines the help available for families and sets out background information on the Covid-19 Day of Reflection, as well as the UK Covid-19 inquiry.
